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SUMMARY
TB is currently considered to be the most important infectious disease among HIV-1-infected subjects in developing countries, 
such as Brazil. A retrospective analysis of TB cases was performed, occurring from January 1995 to December 2010 in our cohort 
of 599 HIV positive patients. The primary outcome was the occurrence of active TB. Forty-one TB cases were diagnosed over this 
period of 16 years, among 599 HIV positive patients in an open cohort setting in the city of Sao Paulo, Brazil. All-time lowest mean 
CD4 T cell count at the time of TB diagnosis was 146 and 186 cells/mm3, respectively. The mean HIV viral load was 5.19 log
10
 
copies/mL, and 59% of the patients were on HAART. TB incidence was 1.47 per 100 person-years, for a total follow-up time of 2775 
person-years. The probability of surviving up to 10 years after diagnosis was 75% for TB patients as opposed to 96% for patients 
with other, non-TB opportunistic diseases (p = 0.03). TB can be considered a public health problem among people living with HIV 
in Brazil despite of the widespread use of antiretrovirals for the treatment of HIV infection/AIDS.
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INTRODUCTION
In 2008, there were 1.37 million new clinical cases of tuberculosis 
(TB) and an estimated half-million deaths from TB occurred in HIV-
infected persons worldwide3. TB is currently considered to be the most 
important opportunistic infection among HIV-1-infected subjects in 
Brazil1 and is responsible for a substantial proportion of morbidity and 
mortality among HIV-infected patients, with approximately 70,000 new 
cases reported annually3,4,5,13. São Paulo State reported 1/3 of Brazilian 
cases of TB/HIV infection in 20111. In fact, 14% of TB cases in the 
country are associated with HIV infection and TB is the major cause of 
death among HIV-infected patients3. Although TB/HIV co-infection is 
a major public health problem in Brazil, few studies have reported its 
occurrence and clinical outcomes during the HAART era6. Thus, the goal 
of this brief report is to describe the prevalence, incidence and survival of 
TB among HIV/AIDS patients from an HIV outpatient service located in 
the City of São Paulo, one of the areas most affected by HIV in Brazil.
MATERIAL AND METHODS
We retrospectively analyzed cases of active TB diagnosed between 
January 1995 and December 2010 in our cohort of HIV-infected patients. 
This open cohort was made up of HIV-1-infected subjects who had been 
followed for up to 16 years. We classified individuals as having active TB 
if they had at least one positive culture for M. tuberculosis, a positive smear 
for alcohol-acid resistant bacilli, or if they started a TB treatment regimen. 
We defined the date of onset of TB as the date of the first positive smear 
or culture. If neither a smear nor culture result were available before a 
TB treatment regimen was initiated, the starting date of the treatment was 
considered to be the date of onset. All physicians providing care to patients 
were infectious disease specialists, and patients were seen at 4-6 month 
intervals. TB was treated in accordance with Brazilian guidelines for TB 
control2,7. We defined patients as ‘lost to follow up’ if they did not visit the 
clinic within a 6-month period and did not respond to three attempts of us 
contacting them by telephone and/or telegrams. PPD was performed as a 
routine screening at the beginning of the follow up; however, prophylaxis 
was not reported for most patients from this cohort. The study was approved 
by the Ethical Board (Cappesq number 0211/2010). 
Statistical analysis: We analyzed data using Epidata software 
(Centers for Disease Control and Prevention, Atlanta, GA) and compared 
predictor variables among TB/HIV patients and those HIV patients 
without TB. For continuous variables, we used nonparametric Kruskal-
Wallis tests, and for discrete variables we used the Fisher exact test. 
We calculated survival estimates by the Kaplan-Meier method and 
compared survival curves by the log-rank test using Stata 11.0 software 
(Stata Corporation, College Station, TX). A pH value lower than 0.05 
was considered significant. 
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RESULTS
Five hundred and ninety-nine patients were enrolled in the open cohort, 
and 41 (6.8%) met our case definition for TB. Twenty-nine (71%) were 
newly diagnosed with TB, twelve (29%) had known TB at the time of 
cohort entry, and most were on HAART. Thirty patients had pulmonary 
tuberculosis and eleven had extra-pulmonary disease (three patients had 
lymph node tuberculosis, two had intra-abdominal disease, two had 
disseminated tuberculosis, two neuro-tuberculosis, one had pericardial 
and another one had pleural disease). In general, patients with TB were 
younger, more likely to be male, and had higher viral loads (5.76 log
10
 
copies/mL vs. 4.65 log
10
 copies/mL) at the time of TB diagnosis than those 
without TB, although none of those characteristics has reached statistical 
significance (Table 1). Twenty-one TB patients were on HAART, but only 
three had undetectable viral loads. The remaining 20 patients were not on 
antiretrovirals. Among patients with other, non-TB opportunistic infections 
59 had detectable viral loads, while 19 had undetectable levels.
Tuberculosis incidence was 1.47 cases per 100 person-years over a 
total cohort follow-up time of 2775 person-years. Comparing patients 
diagnosed with TB to those diagnosed with other AIDS-defining 
opportunistic infections, eight (19.5%) of 41 patients with TB were lost 
to follow up and six (14.6%) died, in comparison with eight deaths (4.8%) 
among 168 non-TB AIDS patients. All TB patients who died were on 
HAART, five of them with rescue regimens. Death rates were 2.17 per 
100 person-year among TB patients and 0.9 per 100 person-years among 
non-TB AIDS patients. The probability of surviving up to 10 years after 
diagnosis was 75% for TB patients as opposed to 96% for patients with 
other, non-TB opportunistic infections (p = 0.03) (Fig. 1). 
DISCUSSION
We found that 6.8% of HIV-infected patients in our cohort had TB 
on cohort entry or developed it during follow up, corresponding to an 
incidence of 1.47 cases per 100 person-year. TB is endemic in Brazil, 
especially in metropolitan areas where the living conditions and poverty 
of parts of the population facilitate the spread of airborne diseases. The 
relatively high incidence of TB in our study population of HIV-infected 
patients is similar to that found by other investigators studying poor, 
urban populations in Latin America2,6. 
We also found that TB was an important cause of mortality in our 
study, with six confirmed deaths and eight lost to follow up, some or all of 
whom may have died from TB, although we were unable to ascertain this 
fact. This number, although substantially lower than the numbers found 
in several African countries where TB reaches up to 90% of prevalence 
among AIDS patients8, is nonetheless a cause for concern since the 
risk of dying from TB is more than twice that of dying from any other 
opportunistic disease9. Even so, confirmed mortality from TB was not 
as high in this cohort (1%) as it is in Africa and Asia, possibly due to 
the more widespread use of ART10, as well as to an earlier diagnosis of 
HIV infection11,12 . In this respect, we found that only slightly more than 
half of our TB/HIV patients were on HAART, and just three of them 
had undetectable viral loads, suggesting an unsatisfactory adherence to 
treatment. 
Our findings provide evidence in support of the current Brazilian 
national tuberculosis treatment guidelines, which recommend an 
Table 1




Non-TB AIDS cases 
(n=168)
p value
Age (mean ±sd) years 41.2 (9.4) 43.4 (10.4) 0.5
Gender (% male) 78.0 72.6 0.6
Mean time of HIV infection to disease diagnosis (years) 5.96 2.44 0.01
Nadir of T CD4 cells/mm3 (Median, 25%-75%) 173 (73-249) 150 (58-239) 0.7
T CD4 cells/mm3 at disease diagnosis (Median, 25%-75%) 193 (66-404) 167 (178-344) 0.6
Proportion on HAART(%) 59 48 0.8
RNA HIV viral load log
10
/mL 5.19 (4.03-5.7) 4.65 (4.1-5.3) 0.7
Deaths, n (%) 6 (15) 8 (5) 0.03
ns: Not statistically significant; * All comparisons between TB/HIV cases vs Non-TB AIDS cases.
Fig. 1 - Survival estimates of AIDS patients with tuberculosis and of AIDS patients with 
other opportunistic diseases. São Paulo, Brazil, 1995-2010. Notes: Analysis time in days; 
D = Patients with other opportunistic non-TB diseases; TB = Patients with tuberculosis; * 
Log-rank test. 
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evaluation of HIV-infected patients for TB on entry into care and to treat 
those found to be infected regardless of clinical stage. In our cohort, all 
patients with clinical TB received a TB treatment regimen based on the 
then-current guidelines, which consisted of triple anti-TB therapy for 
six months (rifampin, isoniazid and pyrazinamide). More recently, the 
national treatment guidelines have been reviewed to include ethambutol 
in the treatment regimen and to provide drugs in a fixed-dose combination 
once daily for six months, free of charge2. 
There are several limitations for this study. Firstly, this study was 
conducted in a tertiary care hospital, and patient care provided in our 
institution may not be representative of care in other types of clinical 
facilities in Brazil. Secondly, as this was an observational study, we were 
unable to control adherence, which could have led to an underestimation 
of the effectiveness of TB treatment in this population. Finally, much 
of the data regarding isoniazid prophylaxis was not systematically 
recorded, and so we were unable to determine the impact of this important 
intervention on TB incidence. 
However, despite these limitations, we believe that our finding that 
TB is a major cause of morbidity and mortality is valid, despite the 
widespread use of ART in Brazil. This in turn suggests the need for 
additional interventions, such as the use of new diagnostic tools, INH 
prophylaxis and directly observed therapy to minimize the burden of 
HIV-related TB in Brazil. Thus the early diagnosis and treatment, either 
of TB and HIV infection, the identification of risk factors and the use of 
INH, should be improved in this population.
RESUMO
Tuberculose entre pacientes infectados pelo HIV-1 em ambulatório 
terciário de São Paulo, Brasil
Atualmente, a tuberculose (TB) é considerada a doença infecciosa 
mais importante entre os pacientes infectados pelo HIV-1 nos países 
em desenvolvimento, como o Brasil. Análise retrospectiva dos casos de 
tuberculose ocorridos a partir de janeiro 1995 até dezembro de 2010 foi 
realizada em nossa coorte de 599 pacientes HIV positivos. O desfecho 
primário foi a ocorrência de TB ativa, e 41 casos da doença foram 
diagnosticados durante este período de 16 anos. As contagens médias 
do nadir de células T CD4 e ao momento do diagnóstico de TB foram 
de 146 e 217 células/mm3, respectivamente. A carga viral média de HIV 
foi de 5,19 log
10
 cópias/mL, e 59% dos pacientes estavam em tratamento 
com ART. A incidência de TB foi de 1,47 casos por 100 pessoas-ano, 
para um tempo total de seguimento da coorte de 2775 pessoas-ano. 
A probabilidade de sobreviver até 10 anos após o diagnóstico foi de 
75% para pacientes com TB, em oposição a 96% para pacientes com 
outras doenças oportunistas não-TB (p = 0,03). A tuberculose pode ser 
considerada problema de saúde pública entre as pessoas que vivem 
com HIV no Brasil, apesar da ampla utilização de anti-retrovirais para 
o tratamento da infecção pelo HIV / AIDS
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